However, others have found a proinflammatory cytokine profile in patients with IIH, with significant elevations in IL-2 and IL-17 in the CSF of patients with IIH compared with controls with other neurological conditions
How often should I get this while on GLP-1 medication
N Engl J Med 375:18341844 Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, hman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF (2017) EXSCEL Study Group
Tirzepatide appears to have a peculiar impact on atherogenic dyslipidemia compared to GLP-1R monoagonists, with a preferential benefit on triglyceride levels [78, 79]
Characterization of a delta-electroencephalogram (-sleep)-inducing peptide